FOUSE JACQUALYN A 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
FOUSE JACQUALYN A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-10+1,579→ 1,579 totalExercise: $329.16Exp: 2035-03-10→ Common Stock (1,579 underlying) - Award
Common Stock
2025-03-10+894→ 894 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest as to 50% of the shares on each of March 10, 2026 and March 10, 2027, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The option vests as to 50% of the shares on the first anniversary of the date of grant (March 10, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.